abrdn plc Invests $3.77 Million in Grail, Inc. (NASDAQ:GRAL)

abrdn plc purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 211,068 shares of the company’s stock, valued at approximately $3,768,000. abrdn plc owned approximately 0.63% of Grail as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of GRAL. Douglas Lane & Associates LLC bought a new stake in shares of Grail in the 4th quarter worth approximately $3,034,000. A. D. Beadell Investment Counsel Inc. bought a new stake in shares of Grail during the fourth quarter worth approximately $430,000. FNY Investment Advisers LLC bought a new position in Grail during the fourth quarter worth about $26,000. 180 Wealth Advisors LLC bought a new stake in shares of Grail in the 4th quarter valued at $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new stake in Grail during the 4th quarter worth approximately $387,000.

Insider Transactions at Grail

In related news, CFO Aaron Freidin sold 30,452 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares in the company, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Grail Trading Down 2.4 %

Shares of NASDAQ GRAL opened at $32.21 on Monday. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $35.67. The firm’s 50-day moving average price is $21.72 and its 200-day moving average price is $17.17.

Grail (NASDAQ:GRAL) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The company had revenue of $28.65 million for the quarter. On average, analysts predict that Grail, Inc. will post -65.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Guggenheim started coverage on shares of Grail in a research report on Thursday, October 17th. They set a “neutral” rating on the stock. Morgan Stanley initiated coverage on Grail in a research note on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price for the company. Finally, Wolfe Research assumed coverage on Grail in a research note on Friday, November 15th. They issued a “peer perform” rating for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.